Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on June 8, 2026

13 minutes ago

Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program

Indeterminate GlobeNewswire

13 minutes ago

Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission

Indeterminate GlobeNewswire

13 minutes ago

Zevra Therapeutics Announces Orange Book Listing of U.S. Patent Strengthening Exclusivity for MIPLYFFA

Indeterminate GlobeNewswire

13 minutes ago

Standard BioTools and Treeline Biosciences Announce Merger Agreement

Indeterminate GlobeNewswire

38 minutes ago

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

Indeterminate GlobeNewswire

43 minutes ago

MitoRx Therapeutics presents promising preclinical data on MTRX31, a mitochondrial-targeted small molecule for metabolically unhealthy obesity, at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire

43 minutes ago

Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)

Indeterminate GlobeNewswire

43 minutes ago

Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses

Indeterminate GlobeNewswire

43 minutes ago

Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

Indeterminate GlobeNewswire

43 minutes ago

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

Indeterminate GlobeNewswire

43 minutes ago

Sequel Presents Pivotal Trial of the twiist™ Automated Insulin Delivery System in Adults with Insulin-Treated Type 2 Diabetes at the ADA 86th Scientific Sessions

Indeterminate GlobeNewswire

43 minutes ago

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Indeterminate GlobeNewswire

43 minutes ago

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

Indeterminate GlobeNewswire

43 minutes ago

Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

Indeterminate GlobeNewswire

44 minutes ago

Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

Indeterminate GlobeNewswire

an hour ago

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Indeterminate GlobeNewswire

an hour ago

Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression

Indeterminate GlobeNewswire

2 hours ago

Shattuck Labs Announces Phase 1 Results for SL-325

Indeterminate GlobeNewswire

2 hours ago

Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion 

Indeterminate GlobeNewswire

4 hours ago

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

Indeterminate GlobeNewswire